Quick Answer
Nuo Therapeutics, Inc. reported R&D Expense of $0.00 for fiscal year 2021.
Nuo Therapeutics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $0.00 | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $181.2K | -68.6% |
| 2018 | $576.2K | -56.6% |
| 2017 | $1.33M | -47.9% |
| 2015 | $2.55M | -36.8% |
| 2014 | $4.04M | +6.3% |
| 2013 | $3.80M | +12.2% |
| 2012 | $3.39M | +3350.3% |
| 2011 | $98.1K | -76.4% |
| 2010 | $415.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $2.7K | -97.2% | -96.8% |
| June 30, 2019 | $84.1K | -39.9% | -10.8% |
| March 31, 2019 | $94.3K | -63.4% | -1.2% |
| September 30, 2018 | $95.5K | -68.1% | -31.8% |
| June 30, 2018 | $140.1K | -54.7% | -45.7% |
| March 31, 2018 | $258.0K | -35.4% | -13.8% |
| September 30, 2017 | $299.5K | -7.4% | -3.2% |
| June 30, 2017 | $309.5K | +37.9% | -22.5% |
- Over the 2010–2021 period, Nuo Therapeutics, Inc.’s r&d expense has declined by 100.0% (from $415.6 thousand to $0.00).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on April 15, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: